Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV 95% CI) | AUC | Women Who Would Be Sent for Screening, n (%) | |
---|---|---|---|---|---|---|
ORAI ≥5 | 94 (82–98) | 19 (15–25) | 19 (15–25) | 94 (82–98) | 0.57 | 240 (83) |
OST <6 | 90 (77–96) | 25 (20–32) | 20 (15–26) | 92 (82–97) | 0.58 | 224 (77) |
SCORE ≥4 | 88 (75–95) | 28 (22–34) | 20 (15–26) | 92 (82–97) | 0.58 | 217 (75) |
FRAX ≥4.7% | 90 (77–96) | 17 (13–23) | 18 (13–24) | 89 (76–96) | 0.54 | 243 (84) |
FRAX ≥6.8% | 66 (51–78) | 51 (45–58) | 22 (16–30) | 88 (81–93) | 0.59 | 149 (51) |
AUC, area under the receiver operating characteristic curve; CI, confidence interval; FRAX, Fracture Risk Assessment Tool; NPV, negative predictive value; ORAI, Osteoporosis Risk Assessment Instrument; OST, Osteoporosis Self-Assessment Tool; PPV, positive predictive value; SCORE, Simple Calculated Osteoporosis Risk Estimation.